• Maeve Muldowney, Pudkrong Aichholz, Rajen Nathwani, Lynn G Stansbury, John R Hess, and Monica S Vavilala.
• Department of Anesthesiology and Pain Medicine, Harborview Medical Center.
• Curr Opin Anaesthesiol. 2022 Apr 1; 35 (2): 176181176-181.

Purpose Of ReviewDespite significant advances in trauma management over the last twenty years, uncontrolled hemorrhage remains the leading cause of preventable death in trauma. We review recent changes affecting hemorrhage control resuscitation.Recent FindingsEarly blood product usage has become well established as a standard of care in trauma hemorrhage control. To enable this, low titer group A liquid plasma and group O whole blood are increasingly utilized. Single donor apheresis platelets have now replaced pooled donor platelets in the USA and are often pathogen reduced, which has implications for trauma resuscitation. Further work is examining timing and dosing of tranexamic acid and the debate in factor concentrate usage in trauma induced coagulopathy continues to evolve. The 'Stop the bleed' campaign has highlighted how important the use of hemostatic dressings are in hemorrhage control, as too is the expanded use of endovascular aortic occlusion. We highlight the ongoing research into desmopressin use and the undetermined significance of ionized calcium levels in trauma. Finally, we discuss our own hospital experience with coagulation testing and the paucity of evidence of improved outcomes with viscoelastic testing.SummaryImproving trauma coagulopathy diagnostics and hemorrhage control are vital if we are to decrease the mortality associated with trauma.Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

23 keywords...

hide…